Targeting the Glutamatergic System to Treat Pathological Gambling: Current Evidence and Future Perspectives

Pathological gambling or gambling disorder has been defined by the DSM-5 as a behavioral addiction. To date, its pathophysiology is not completely understood and there is no FDA-approved treatment for gambling disorders. Glutamate is the principal excitatory neurotransmitter in the nervous system an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pettorruso, Mauro, De Risio, Luisa, Martinotti, Giovanni, Di Nicola, Marco, Ruggeri, Filippo, Conte, Gianluigi, Di Giannantonio, Massimo, Janiri, Luigi
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2014
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4075088/
https://ncbi.nlm.nih.gov/pubmed/25013755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/109786
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares